KAT2A and neoplasm: Correlation analysis was then conducted and suggested that KAT2A expression levels were positively associated with the clinical risk factors based on the TCGA-KIRC cohort, including pathological stages, tumor grades, or TNM stages (Figures 1D,E and Supplementary Figure 1A).